Skip to main content
. 2022 Mar 28;71(11):2631–2643. doi: 10.1007/s00262-022-03185-6

Fig. 5.

Fig. 5

Prior nivolumab treatment associated with worse progression-free survival (PFS) and overall survival (OS). Kaplan–Meier curves of a PFS according to RECIST v1.1; b OS stratified by nivolumab experience